Loading...
Uploaded by moneycontrol on Dec 1, 2009
Templeton, which owns 10% stake in Taro has withdrawn from Taro's appeal against Sun Pharma, reports CNBC-TV18s Archi Damania.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)